SG11201610217YA - 2-(3-pyridinyl)-1h-benzimidazole derivative compound and medicine containing same - Google Patents
2-(3-pyridinyl)-1h-benzimidazole derivative compound and medicine containing sameInfo
- Publication number
- SG11201610217YA SG11201610217YA SG11201610217YA SG11201610217YA SG11201610217YA SG 11201610217Y A SG11201610217Y A SG 11201610217YA SG 11201610217Y A SG11201610217Y A SG 11201610217YA SG 11201610217Y A SG11201610217Y A SG 11201610217YA SG 11201610217Y A SG11201610217Y A SG 11201610217YA
- Authority
- SG
- Singapore
- Prior art keywords
- pyridinyl
- derivative compound
- containing same
- medicine containing
- benzimidazole derivative
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K51/0455—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/05—Isotopically modified compounds, e.g. labelled
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2014131934 | 2014-06-26 | ||
| PCT/JP2015/068431 WO2015199205A1 (en) | 2014-06-26 | 2015-06-25 | 2-(3-pyridinyl)-1h-benzimidazole derivative compound and medicine containing same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201610217YA true SG11201610217YA (en) | 2017-01-27 |
Family
ID=54938282
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201610217YA SG11201610217YA (en) | 2014-06-26 | 2015-06-25 | 2-(3-pyridinyl)-1h-benzimidazole derivative compound and medicine containing same |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US10189815B2 (en) |
| EP (1) | EP3162802B1 (en) |
| JP (1) | JP6636921B2 (en) |
| KR (1) | KR20170017871A (en) |
| CN (1) | CN106458995B (en) |
| AU (1) | AU2015281060B2 (en) |
| CA (1) | CA2953692A1 (en) |
| ES (1) | ES2821273T3 (en) |
| MX (1) | MX2016017405A (en) |
| SG (1) | SG11201610217YA (en) |
| WO (1) | WO2015199205A1 (en) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2017278446A1 (en) * | 2016-06-10 | 2018-12-20 | Nihon Medi-Physics Co., Ltd. | Non-invasive diagnostic imaging agent for heart disease |
| ES2909126T3 (en) | 2017-03-07 | 2022-05-05 | Nihon Mediphysics Co Ltd | Radioactive fluorine labeled precursor compound and method for producing a radioactive fluorine labeled compound using the same |
| WO2018235535A1 (en) | 2017-06-23 | 2018-12-27 | 日本メジフィジックス株式会社 | Production method for radiohalogen-labeled compound and production method for raidopharmaceutical |
| JP7054134B2 (en) * | 2017-12-07 | 2022-04-13 | 国立大学法人京都大学 | Benzo [b] carbazole compound and imaging using it |
| US11266753B2 (en) | 2017-12-28 | 2022-03-08 | Nihon Medi-Physics Co., Ltd. | 2-[5-(imidazol-1-ylmethyl)pyridin-3-yl]benzimtdazole derivative compound, and medicament including same |
| JP2021130610A (en) * | 2018-05-08 | 2021-09-09 | 日本メジフィジックス株式会社 | Non-invasive diagnostic imaging agent for heart disease |
| JP2021181404A (en) * | 2018-08-23 | 2021-11-25 | 日本メジフィジックス株式会社 | Solution containing labeled precursor compound of radioactive fluorine-labeled compound |
| WO2020085238A1 (en) * | 2018-10-24 | 2020-04-30 | 日本メジフィジックス株式会社 | Salt of radioactive fluorine-labeled precursor compound |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007144725A2 (en) | 2006-06-09 | 2007-12-21 | Ge Healthcare Limited | SYNTHESIS AND EVALUATION OF 18F-LABELLED ALKYL-1-[(R)-1-PHENYLETHYL]-1H-IMIDAZOLE-5-CARBOXYLATE AS A TRACER FOR THE QUANTIFICATION OF β-11-HYDROXYLASE ENZYME IN THE ADRENAL GLANDS |
| EP2394668A1 (en) | 2010-06-01 | 2011-12-14 | Julius-Maximilians-Universität Würzburg | PET radiopharmaceuticals for differential diagnosis between bilateral and unilateral conditions of primary hyperaldosteronism |
| EP2595482A4 (en) | 2010-07-21 | 2013-12-25 | Merck Sharp & Dohme | Aldosterone synthase inhibitors |
| JP2015110563A (en) * | 2013-11-08 | 2015-06-18 | 日本メジフィジックス株式会社 | Aldosterone synthase inhibitor |
-
2015
- 2015-06-25 US US15/321,972 patent/US10189815B2/en active Active
- 2015-06-25 ES ES15811977T patent/ES2821273T3/en active Active
- 2015-06-25 AU AU2015281060A patent/AU2015281060B2/en not_active Ceased
- 2015-06-25 MX MX2016017405A patent/MX2016017405A/en unknown
- 2015-06-25 SG SG11201610217YA patent/SG11201610217YA/en unknown
- 2015-06-25 KR KR1020167028804A patent/KR20170017871A/en unknown
- 2015-06-25 CN CN201580032760.3A patent/CN106458995B/en active Active
- 2015-06-25 JP JP2016529669A patent/JP6636921B2/en active Active
- 2015-06-25 CA CA2953692A patent/CA2953692A1/en not_active Abandoned
- 2015-06-25 EP EP15811977.6A patent/EP3162802B1/en active Active
- 2015-06-25 WO PCT/JP2015/068431 patent/WO2015199205A1/en active Application Filing
-
2018
- 2018-12-06 US US16/211,434 patent/US10358434B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US20190169169A1 (en) | 2019-06-06 |
| US10358434B2 (en) | 2019-07-23 |
| ES2821273T3 (en) | 2021-04-23 |
| CN106458995B (en) | 2019-12-20 |
| US20170158668A1 (en) | 2017-06-08 |
| EP3162802B1 (en) | 2020-08-19 |
| AU2015281060B2 (en) | 2019-03-14 |
| JPWO2015199205A1 (en) | 2017-04-20 |
| WO2015199205A1 (en) | 2015-12-30 |
| EP3162802A4 (en) | 2018-01-17 |
| CN106458995A (en) | 2017-02-22 |
| JP6636921B2 (en) | 2020-01-29 |
| CA2953692A1 (en) | 2015-12-30 |
| MX2016017405A (en) | 2017-08-24 |
| AU2015281060A1 (en) | 2017-01-05 |
| KR20170017871A (en) | 2017-02-15 |
| US10189815B2 (en) | 2019-01-29 |
| EP3162802A1 (en) | 2017-05-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1255102A1 (en) | Heterocyclic compounds and uses thereof | |
| HK1223100A1 (en) | Heterocyclic compounds | |
| IL247018A0 (en) | Heterocyclic compound | |
| HRP20182134T1 (en) | Triazine compound and use thereof for medical purposes | |
| SG11201610217YA (en) | 2-(3-pyridinyl)-1h-benzimidazole derivative compound and medicine containing same | |
| IL285105A (en) | Heterocyclic compound | |
| HK1245092A1 (en) | Poultice | |
| SG11201606199SA (en) | Ketoprofen-containing poultice | |
| PT3202759T (en) | Alpha-aminoamide derivative compound and pharmaceutical composition comprising same | |
| EP3197885A4 (en) | Heterocyclic compounds and use thereof | |
| IL250729B (en) | Pyrazolothiazole compound and medicine comprising same | |
| PL3159335T3 (en) | Novel heterocyclic compound | |
| PT3268356T (en) | Heterocyclic compounds and methods for their use | |
| GB201416351D0 (en) | Heterocyclic derivatives | |
| ZA201700664B (en) | Azole benzene derivative and crystalline form thereof | |
| GB201610823D0 (en) | Heterocyclic compounds and medical uses | |
| TH1501004592A (en) | Enclosures for treatment materials |